Human Therapeutic Targets and Modulators Thereof
US-2024120023-A1 · Apr 11, 2024 · US
US12456540B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12456540-B2 |
| Application number | US-202117158942-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 26, 2021 |
| Priority date | Nov 16, 2016 |
| Publication date | Oct 28, 2025 |
| Grant date | Oct 28, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for identifying biosynthetic gene clusters that include genes for producing compounds that interact with specific target proteins are disclosed. Some methods relate to bioinformatics methods for identifying and/or prioritizing biosynthetic gene clusters. Related systems, components, and tools for the identification and expression of such gene clusters are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A method for producing a small molecule to screen for inhibition of a first target protein, the method comprising: identifying a fungal protein based on its similarity to a first target protein, wherein the fungal protein has at least 60% sequence identity to the first target protein; identifying a fungal gene cluster that is within 20,000 bases of a genomic region that encodes the fungal protein; expressing the fungal gene cluster or a plurality of genes from the fungal gene cluster in a host cell to produce a compound; isolating the compound produced by the fungal gene cluster or the plurality of genes from the fungal gene cluster; and screening the isolated compound for inhibition of an activity of the first target protein; wherein the first target protein is a mammalian protein. 2. The method of claim 1 , wherein the gene cluster includes a coding sequence for a protein that is an extracellular protein, a membrane tethered protein, a protein involved in a transport or secretion pathway, a protein homologous to a protein involved in a transport or secretion pathway, a protein with a peptide targeting signal, a protein with a terminal sequence with homology to a targeting signal, an enzyme that degrades small molecules, or a protein with homology to an enzyme that degrades small molecules. 3. The method of claim 1 , wherein the host cell is a yeast cell. 4. The method of claim 1 , wherein each expressed gene of the plurality of genes from the gene cluster is expressed under the control of a different promoter. 5. The method of claim 1 , wherein the protein that has at least 60% sequence identity to the first target protein has greater than 80% sequence identity to the first target protein. 6. The method of claim 1 , wherein the protein that has at least 60% sequence identity to the previously identified first target protein has greater than 90% sequence identity to the first target protein. 7. The method of claim 1 , wherein the first target protein is a human protein. 8. The method of claim 7 , wherein the fungal gene cluster is selected from the group consisting of (1) a cluster that comprises one or more polyketide synthases and (2) a cluster that comprises one or more non-ribosomal peptide synthetases, (3) a cluster that comprises one or more terpene synthases, (4) a cluster that comprises one or more UbiA-type terpene cyclases, and (5) a cluster that comprises one or more dimethylallyl transferases. 9. The method of claim 1 , wherein the host cell is a non-yeast fungus.
Vectors or expression systems specially adapted for eukaryotic hosts · CPC title
Sequence alignment; Homology search · CPC title
ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks · CPC title
ICT specially adapted for sequence analysis involving nucleotides or amino acids · CPC title
ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.